ChemicalBook > CAS DataBase List > N-(CYCLOPROPYLMETHOXY)-3,4,5-TRIFLUORO-2-[(4-IODO-2-METHYLPHENYL)AMINO]-BENZAMIDE
N-(CYCLOPROPYLMETHOXY)-3,4,5-TRIFLUORO-2-[(4-IODO-2-METHYLPHENYL)AMINO]-BENZAMIDE
N-(CYCLOPROPYLMETHOXY)-3,4,5-TRIFLUORO-2-[(4-IODO-2-METHYLPHENYL)AMINO]-BENZAMIDE
- CAS No.212631-61-3
- Chemical Name:N-(CYCLOPROPYLMETHOXY)-3,4,5-TRIFLUORO-2-[(4-IODO-2-METHYLPHENYL)AMINO]-BENZAMIDE
- CBNumber:CB72448962
- Molecular Formula:C18H16F3IN2O2
- Formula Weight:476.23
- MOL File:212631-61-3.mol
N-(CYCLOPROPYLMETHOXY)-3,4,5-TRIFLUORO-2-[(4-IODO-2-METHYLPHENYL)AMINO]-BENZAMIDE Property
- Melting point 125-127 °C
- Density 1.686±0.06 g/cm3(Predicted)
- storage temp. Store at +4°C
- solubility Soluble in DMSO
- form solid
- pka -3.95±0.50(Predicted)
- color White
- FDA UNII WQ5121ZGT3
- UNSPSC Code 12352200
- Symbol(GHS)
- Signal word
- Hazard statements
- Precautionary statements
N-(CYCLOPROPYLMETHOXY)-3,4,5-TRIFLUORO-2-[(4-IODO-2-METHYLPHENYL)AMINO]-BENZAMIDE Price
More Price(1)
- Brand: Sigma-Aldrich(India)
- Product number: 444965
- Product name : MEK Inhibitor VIII - CAS 212631-61-3 - Calbiochem
- Purity: The MEK1/2 Inhibitor II, also referenced under CAS 212631-61-3, controls the biological activity of MEK1/2. This small molecule/inhibitor is primarily
- Packaging: 5MG
- Price: ₹20250
- Updated: 2022/06/14
- Buy: Buy
N-(CYCLOPROPYLMETHOXY)-3,4,5-TRIFLUORO-2-[(4-IODO-2-METHYLPHENYL)AMINO]-BENZAMIDE Chemical Properties,Usage,Production
- Description PD 198306 is an orally bioavailable and potent inhibitor of MAPK kinase 1/2 (MEK1/2; IC50 = 8 nM). It is selective for MEK1/2 over ERK, c-Src, PI3Kγ, and cyclin-dependent kinases (IC50s = >1 μM). PD 198306 (3-100 μM) reduces ERK1/2 phosphorylation and inhibits growth of HL-60 cells in vitro. In vivo, PD 198306 (10-30 mg/kg) reduces ERK1/2 phosphorylation and matrix metalloproteinase-1 (MMP-1) expression in a dose-dependent manner in a rabbit model of osteoarthritis. It also reduces ERK1/2 activity in the lumbar spinal cord and blocks static allodynia in rat models of neuropathic pain induced by streptozotocin or chronic constriction injury.
- Uses PD 198306 is a cell-permeable and highly selective potent inhibitor of MEK 1/2.
- Definition ChEBI: N-(cyclopropylmethoxy)-3,4,5-trifluoro-2-(4-iodo-2-methylanilino)benzamide is an aminobenzoic acid.
- Biological Activity Potent inhibitor of MEK1/2. Inhibits isolated enzyme at a concentration of 8 nM and inhibits MEK activity in synovial fibroblasts at concentrations of 30-100 nM. Highly selective for MEK; IC 50 values are > 1, > 4, > 4 and > 10 μ M for ERK, c-Src, cdks and PI 3-kinase γ respectively. Antihyperalgesic; blocks static allodynia in the streptozocin model of neuropathic pain following i.t. administration.
- in vitro pd 198306 inhibits the isolated mek at a concentration of 8 nm and inhibits mek activity in synovial fibroblasts at 30–100 nm, depending on the species. pd 198306 is highly selective for mek and has a ic50 of >4 um for c-src, >1 um for erk, >4 um for cyclin-dependent kinases and >10 um for phosphatidylinositol 3-kinase [1].
- in vivo rabbits treated with pd 198306 showd a significant dose-dependent reduction in the level of phospho-erk-1/2 and a lower level of mmp-1. pd 198306 can partially decrease the development of some of the structural changes in experimental rabbit model of osteoarthritis [1]. pd 198306 dose-dependently blocked static allodynia in both the streptozocin and the chronic constriction injury models of neuropathic pain. these antihyperalgesic effects correlated with a reduction in the elevated levels of active erk1 and 2 in lumbar spinal cord [2].
- IC 50 8 nm for mek [1]
- storage Store at +4°C
-
References
[1] pelletier jp, fernandes jc, brunet j, moldovan f, schrier d, flory c, martel-pelletier j. in vivo selective inhibition of mitogen-activated protein kinase kinase 1/2 in rabbit experimental osteoarthritis is associated with a reduction in the development of structural changes. arthritis rheum. 2003 jun;48(6):1582-93.
[2] ciruela a, dixon ak, bramwell s, gonzalez mi, pinnock rd, lee k. identification of mek1 as a novel target for the treatment of neuropathic pain. br j pharmacol. 2003 mar;138(5):751-6.
N-(CYCLOPROPYLMETHOXY)-3,4,5-TRIFLUORO-2-[(4-IODO-2-METHYLPHENYL)AMINO]-BENZAMIDE Preparation Products And Raw materials
Raw materials
Preparation Products
Global(41)Suppliers
-
Supplier:
- Tel:+1-781-999-5354<br/>+1-00000000000
- Email:marketing@targetmol.com
- Country:United States
- ProdList:32202
- Advantage:58
-
Supplier:
- Tel:
- Email:tp@aladdinsci.com
- Country:United States
- ProdList:57505
- Advantage:58
- Supplier: EMMX Biotechnology LLC
- Tel:888-539-0666
- Email:info@emmx.com
- Country:United States
- ProdList:8447
- Advantage:60
- Supplier: Shanghai YuanYe Biotechnology Co., Ltd.
- Tel:021-61312847;<br/>18021002903
- Email:3008007409@qq.com
- Country:China
- ProdList:71829
- Advantage:60
- Supplier: Tianjin Kailiqi Biotechnology Co., Ltd.
- Tel: 15076683720
- Email:klq@cw-bio.com
- Country:China
- ProdList:6345
- Advantage:55
- Supplier: ChemeGen(Shanghai) Biotechnology Co.,Ltd.
- Tel: 18818260767
- Email:sales@chemegen.com
- Country:China
- ProdList:11218
- Advantage:58
- Supplier: ShangHai ChuanQian Chemcial Technique Centre
- Tel: 15869524721
- Email:3525679403@qq.com
- Country:China
- ProdList:4348
- Advantage:58
- Supplier: Energy Chemical
- Tel:021-58432009<br/>400-005-6266
- Email:marketing1@energy-chemical.com
- Country:China
- ProdList:44814
- Advantage:58
- Supplier: MedBioPharmaceutical Technology Inc
- Tel:021-69568360<br/>18916172912
- Email:order@med-bio.cn
- Country:China
- ProdList:8140
- Advantage:58
212631-61-3, N-(CYCLOPROPYLMETHOXY)-3,4,5-TRIFLUORO-2-[(4-IODO-2-METHYLPHENYL)AMINO]-BENZAMIDERelated Search:
- 酶
- 抑制剂
- C18H16F3IN2O2
- 化合物PD 198306,10 MM DMSO 溶液
- PD 198306,MEK1 / 2的抑制剂
- N-(环丙基甲氧基)-3,4,5-三氟-2-((4-碘-2-甲基苯基)氨基)苯甲酰胺
- 化合物PD 198306
- 212631-61-3
- MEK Inhibitor VIII
- PD 198306, 10 mM in DMSO
- MAPK,inhibit,neuropathic,Inhibitor,MAP2K,rabies,mitogen-activated protein,drug,MAPKK,PD-198306,phosphatases,PD 198306,inositol,RNA,pain,interference,MEK,ERK,antihyperalgesic,screening,Mitogen-activated protein kinase kinase,phosphate,kinases,PD198306
- Benzamide, N-(cyclopropylmethoxy)-3,4,5-trifluoro-2-[(4-iodo-2-methylphenyl)amino]-
- N-(cyclopropylmethoxy)-3,4,5-trifluoro-2-(4-iodo-2-methylanilino)benzamide
- PD 198306
- N-(CYCLOPROPYLMETHOXY)-3,4,5-TRIFLUORO-2-[(4-IODO-2-METHYLPHENYL)AMINO]-BENZAMIDE